In recent years, there has been a virtual explosion in the growth of Medical Science Liaisons (MSLs). Over the next two years, in fact, the number of MSLs is expected to increase globally by an impressive 20%. What’s driving this growth? For starters, KOLs are demanding it. Today’s thought leaders are looking for more detailed information as they seek to engage in thorough clinical conversations with representatives from life sciences companies. Robert Groebel, VP of Global Medical Strategy for Veeva explains in this month’s Medical Marketing & Media.